ClinicalTrials.Veeva

Menu

Randomized Study on the Effects of Moderate Anaemia in Free Microvascular Tissue Transfer

University of Zurich (UZH) logo

University of Zurich (UZH)

Status

Withdrawn

Conditions

Open Fracture of Foot
Tumor

Study type

Observational

Funder types

Other

Identifiers

NCT01848431
FF-HTC Verson 1-3

Details and patient eligibility

About

The evaluation of Perfusion of free flaps in patients with moderate anaemia and possible reduction of the transfusion threshold.

  • Trial with surgical intervention

Full description

In study group 1 patients will be kept at a hematocrit level below 28% and only receive transfusions if symptomatic or the fall below 25%. Patients in group 2 will receive transfusions to reach a hematocrit always above 30%.

Tissue perfusion in free flaps will be measured with indocyanine green fluorescence angiography, confocal microscopy and oxygen partial pressure measurement probes.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • planned defect reconstruction with free flap and preoperative hematocrit of 28% or below

Exclusion criteria

  • coagulation disorder
  • Jehovah's witness
  • iodine allergy
  • renal or hepatic insufficiency

Trial design

0 participants in 2 patient groups

anaemia group
Description:
no blood transfusions will be given until hct falls under 25%
normal hct group
Description:
patients in group 2 will receive transfusions as is currently standard protocol outside the study

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems